Page last updated: 2024-10-22

ambroxol and Rhinitis

ambroxol has been researched along with Rhinitis in 1 studies

Ambroxol: A metabolite of BROMHEXINE that stimulates mucociliary action and clears the air passages in the respiratory tract. It is usually administered as the hydrochloride.

Rhinitis: Inflammation of the NASAL MUCOSA, the mucous membrane lining the NASAL CAVITIES.

Research Excerpts

ExcerptRelevanceReference
"Nimesulide treatment for 7 to 10 days is shown to be effective in controlling the inflammatory process in upper airways disorders such as rhinitis, rhinosinusitis, rhinopharyngitis and tubaritis, and in middle ear disorder (secretory otitis media)."5.07Treatment of upper airways inflammation with nimesulide. ( Bellussi, L; Passàli, D, 1993)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bellussi, L1
Passàli, D1

Trials

1 trial available for ambroxol and Rhinitis

ArticleYear
Treatment of upper airways inflammation with nimesulide.
    Drugs, 1993, Volume: 46 Suppl 1

    Topics: Adolescent; Adult; Aged; Ambroxol; Anti-Inflammatory Agents, Non-Steroidal; Child; Drug Therapy, Com

1993